Adhesive Strategies for Erosion-Affected Dentin: A Systematic Review and Meta-Analysis of Bond Durability.
Abstract
Objectives
To systematically evaluate the durability of resin bonding to erosion-affected dentin following adhesive strategies and dentin pretreatments, prioritizing independently replicated aged microtensile bond-strength (µTBS) comparisons. DATA SOURCES Methods: PubMed/MEDLINE, Scopus, Web of Science, and Embase were searched through 21 August 2026. STUDY SELECTION Eligible preclinical studies evaluated bonding to permanent dentin subjected to erosion before adhesive procedures and reported quantitative bond-strength outcomes. Aged µTBS (measured in megapascals [MPa]) was prioritized. Pairwise random-effects meta-analysis was restricted to sufficiently comparable independent studies; Paule-Mandel heterogeneity estimation and safeguarded Hartung-Knapp confidence intervals were used. Single-study and overlapping-cohort effects were reported separately. RoBDEMAT was applied at the item level.
Results
Among 1,163 identified records, 58 retrievable eligible primary reports were retained. At 12-18 months, interface-applied chlorhexidine (CHX) showed numerically lower bond strength than matched erosion-affected dentin controls, but the difference was not statistically significant (k = 3; MD -0.65 MPa; 95% CI -1.83 to +0.52; τ = 0.00). Six-month CHX/protease protocols were not pooled; digitized 72-month DMSO data were kept separate from 48-month data. A hydrophobic resin coating showed a favorable 24-month conditional within-source estimate (MD +17.50 MPa; 95% CI +15.49 to +19.51) from an overlapping publication family. Four-year DMSO and two-year cross-linker findings were favorable in individual studies but lacked independent long-term replication.
Conclusions
Current evidence does not establish a consistently effective bond-preserving pretreatment for erosion-affected dentin. CHX did not demonstrate a detectable benefit at 12-18 months, whereas favorable long-term effects for DMSO, hydrophobic coatings, and selected collagen biomodifiers derive predominantly from single independent studies or one source cohort. Methodological heterogeneity and sparse replication preclude clinical recommendations. CLINICAL
Significance
Laboratory bond-strength outcomes should be interpreted in terms of aging resistance rather than immediate adhesion alone; they do not establish improved restoration survival or justify treatment-specific clinical recommendations.